The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the design that we're working with now is one year on and then the rest of the time off and so those so we'll get have one group that's five years on one group that's one on four off and then placebo that's right blinded across the yeah it's all gonna be a randomized double-blind trial
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so this study that we're designing now is three groups it doesn't have to be but the three groups are a placebo group short-term group so six month or year long treatment and then the continuous treatment group